Delivery Order SPE2DX15D3404-SPE2DX24F1CPU

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $1.6K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,454.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of dexamethasone 10 mg/ml vials, a specialty medication used in various medical treatments. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,512.17, is for the delivery of dexamethasone 10 mg/ml vials to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of February 24, 2025. The contract was not set aside for any specific business type. Amerisourcebergen holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,083.94, is for the delivery of DEXAMETHASONE 20 MG/5 ML VIAL 5ML, a medical product. This is a firm fixed-price Delivery Order contract with an ultimate completion date of June 11, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dexamethasone 10 mg/mL vials. The fixed-price delivery order, valued at $2,176.66, has a period of performance through January 24, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,911,624 units of Dexamethasone 20 mg/5 ml vials, a critical medication. The order has a firm fixed price of $5,562.90 and a completion date of September 24, 2024. Amerisourcebergen, through its extensive pharmaceutical supply chain, will provide this medication to support various military treatment...
This federal contract award, valued at $2,127.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of DEXAMETHASONE 10 MG/ML VIALML, a medical product, with a completion date of February 21, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $1,059.75, is for the delivery of 4,565,815,786 units of Dexamethasone 20 mg/5 ml vials. This is a firm-fixed price delivery order contract with a completion date of September 17, 2024. The contract is not set-aside. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,332.76, is for the delivery of 4566894436 ! DEXAMETHASONE 20 MG/5 ML VIAL 5ML, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,685.10 Firm Fixed Price Delivery Order is for the supply of Dexamethasone 10 mg/ml vials. The contract has an ultimate completion date of February 28, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,033.50 firm-fixed-price delivery order contract is for the provision of 4,567,250 units of dexamethasone 2 mg tablets, a medication used to treat various medical conditions. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
  • SPE2DX15D3404
    Indefinite Delivery Contract
  • SPE2DX15D3404-SPE2DX24F1CPU
    Delivery Order

This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,604.29, is for the delivery of dexamethasone 10 mg/mL vials, a medication used to treat various medical conditions. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. AmerisourceBergen is a for-profit organization that has been registered in the System for Award Management (SAM.gov) since 2002 and specializes in distributing a wide variety of medical products, including specialty medications, generic drugs, brand-name pharmaceuticals, medical devices, and vaccines, to federal government agencies.

Generated 5/17/25, 9:54 AM